Birinyi Associates’s Zimmer Biomet ZBH Stock Holding History

Birinyi Associates’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-2,060	Closed	-$299K	–	81
2019 Q4	$299K	Hold	2,060	–	–	0.12%	70
2019 Q3	$275K	Hold	2,060	–	–	0.12%	75
2019 Q2	$235K	Hold	2,060	–	–	0.1%	73
2019 Q1	$255K	Hold	2,060	–	–	0.11%	68
2018 Q4	$207K	Hold	2,060	–	–	0.1%	74
2018 Q3	$263K	Buy	+2,060	New	+$245K	0.09%	87
2018 Q2	–	Sell	-2,060	Closed	-$218K	–	99
2018 Q1	$218K	Hold	2,060	–	–	0.09%	91
2017 Q4	$241K	Hold	2,060	–	–	0.11%	92
2017 Q3	$234K	Hold	2,060	–	–	0.11%	83
2017 Q2	$257K	Hold	2,060	–	–	0.12%	83
2017 Q1	$244K	Hold	2,060	–	–	0.12%	80
2016 Q4	$206K	Hold	2,060	–	–	0.12%	87
2016 Q3	$260K	Hold	2,060	–	–	0.14%	78
2016 Q2	$241K	Hold	2,060	–	–	0.11%	74
2016 Q1	$213K	Hold	2,060	–	–	0.09%	77
2015 Q4	$205K	Sell	2,060 -309	-13%	-$30.2K	0.13%	76
2015 Q3	$216K	Buy	+2,369	New	+$237K	0.09%	85
2015 Q1	–	Sell	-2,060	Closed	-$227K	–	98
2014 Q4	$227K	Buy	+2,060	New	+$217K	0.1%	83

Other funds holding ZBH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Birinyi Associates's ZBH Position: Q1 2020 in Review

Birinyi Associates sold out of Zimmer Biomet (ZBH) in Q1 2020, closing a stake of 2,060 shares — an estimated $299K sold.

Birinyi Associates first reported a position in ZBH in Q4 2014 and held it in 18 quarters. The position peaked at $299K in Q4 2019. 883 funds tracked by Wall St. Rank hold ZBH as of Q1 2020.

Birinyi Associates reported no remaining Zimmer Biomet position as of Q1 2020 after selling out during the quarter.
Birinyi Associates sold 2,060 Zimmer Biomet shares in Q1 2020, an estimated $299K.
Birinyi Associates first reported a position in Zimmer Biomet in Q4 2014 and held it in 18 quarters.
Birinyi Associates's Zimmer Biomet position peaked at $299K in Q4 2019.
883 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2020.

Based on Birinyi Associates's 13F filing for Q1 2020, filed 12 May 2020.